LB Pharmaceuticals Inc Common Stock
public_traded
LB Pharmaceuticals Inc Common Stock is publicly traded on NASDAQ under ticker LBRX.
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.